TNF and inflammatory bowel disease: A recent study analyzed in 42 IBD patients the in vitro production of TNF from peripheral blood mononuclear cells (PBMC) stimulated with lipopolysaccharide (LPS) and found it to be predictive of clinical response after 6 weeks of infliximab therapy.